News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Fiona BARRY
- Last updated on
Private equity and venture capital firm Frazier Healthcare has a new Operating Executive for its Growth Buyout team in Richard Maroun.
“Rick brings a great deal of expertise and wisdom to Frazier because he intimately understands the challenges that our companies face every day,” said Alan Frazier, founder, Frazier Healthcare. “He is acknowledged in the industry as a leader who can partner with company management.”
Maroun was most recently Senior Vice President and General Counsel of Aptalis Pharma, where he helped engineer Aptalis’ acquisition by Forest Laboratories for $2.9bn. He has also worked for APP Pharmaceuticals, Abraxis BioScience and American BioScience.